Development of a Pathogenesis-Based Therapy for Peeling Skin Syndrome Type 1.

CONCLUSION: The study presents the first preclinical in vitro experiments for a future specific protein replacement therapy for patients suffering from PSS1.
PMID: 32926582 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - September 13, 2020 Category: Dermatology Authors: Valentin F, Wiegmann H, Tarinski T, Nikolenko H, Traupe H, Liebau E, Dathe M, Oji V Tags: Br J Dermatol Source Type: research